Ghana first to approve new Oxford’s R21 vaccine against Malaria

  • 📰 PremiumTimesng
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 78%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Children are at higher risk of the mosquito-borne disease which kills more than 600,000 people each year, according to WHO African Region.

Ghana has approved a new malaria vaccine from Oxford University, becoming the first country in the world to take that step forward in fighting the life-threatening disease.

The effort is one of several focused on addressing the disease that kills over 600,000 each year, most of which are children. The complicated structure and lifecycle of the malaria parasite have long stymied efforts to develop vaccines.The R21/Matrix-M vaccine is the second to ever be approved by the WHO and the first to exceed the WHO threshold of 75 per cent efficacy over 12 months of follow-up.

The first-ever malaria vaccine, RTS,S or mosquirix, from British drugmaker GSK, was approved by the WHO in 2021 after decades of work. But a lack of funding and commercial potential thwarted the company’s capacity to produce as many doses as were needed. At the time mosquirix vaccine was approved, the WHO said it was based on results from an ongoing pilot programme in Ghana, Kenya and Malawi that has reached more than 800,000 children since 2019.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

UNIONBANK_NG bank debited me without my authorisation and not debited alert but my 590k is gone somewhere, They restricted the account about 2month ago and steal me now I call CZ but got no response

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in HEALTH

Health Health Latest News, Health Health Headlines